Eli Lilly Sues US Sellers of Counterfeit Mounjaro Products
Pharmaceutical giant Eli Lilly (NYSE: LLY) has filed a lawsuit in the United States against...
Legal / IP
South Africa’s Competition Commission Investigates J&J for MDR-TB Drug Pricing and Evergreening
The Competition Commission of South Africa has announced an investigation into Johnson & Johnson (J&J;...
Jiangsu Hengrui Pharmaceuticals Entangled in Legal Disputes with BeyondSpring and Reistone
China-based Jiangsu Hengrui Pharmaceuticals Co., Ltd (SHA: 600276) is currently entangled in legal challenges involving...
Janssen Sues Distributors Over Counterfeit Antiretroviral Therapies in the US
Johnson & Johnson’s (J&J; NYSE: JNJ) subsidiary, Janssen, filed a lawsuit last week against pharmaceutical...
Amgen and Horizon Therapeutics Reach Agreement with FTC to Proceed with Acquisition
Amgen (NASDAQ: AMGN) and Horizon Therapeutics (NASDAQ: HZNP) have announced a consent order agreement with...
Scott-Moncrieff & Associates Preparing 50 Cases Against AstraZeneca Over Vaccine Concerns
Scott-Moncrieff & Associates, a UK-based law firm, has disclosed that it is preparing nearly 50...
Pfizer Faces Whistleblower Lawsuit Over Alleged FCPA Violations in China
A former employee of Pfizer Inc., (NYSE: PFE), Frank Han, has filed a civil lawsuit...
Johnson & Johnson Reaches Settlement with Fresenius Kabi and Formycon AG for Stelara Biosimilar
US pharmaceutical giant Johnson & Johnson (J&J; NYSE: JNJ) has entered into its latest settlement...
Nektar Therapeutics and Eli Lilly & Co. Face Off in Court Over REZPEG Partnership Dispute
A legal feud between US-based Nektar Therapeutics (NASDAQ: NKTR) and pharmaceutical giant Eli Lilly &...
Amgen Inc. Reports 7% YOY Revenue Increase in Q2 2023 Financials
US-based biotechnology company Amgen Inc., (NASDAQ: AMGN) has released its financial results for the second...
GSK Files Patent Infringement Lawsuit Against Pfizer’s RSV Vaccine Abrysvo
UK pharmaceutical giant GlaxoSmithKline (NYSE: GSK) has taken US-based Pfizer Inc., (NYSE: PFE) to court,...
National Health Commission’s Anti-Corruption Drive Impacts China’s Pharmaceutical Sector
An anti-corruption crackdown announced by the National Health Commission (NHC) at the end of July...
National Health Commission Launches One-Year Anti-Corruption Campaign in Pharmaceutical Sector
The emergency response department of the National Health Commission (NHC) has released a notification signaling...
Beijing Intellectual Property Court Upholds Validity of Novartis’ Entresto Patent
The Beijing Intellectual Property Court (BIPC) has issued a judgment that reaffirms the validity and...
US Merger Guidelines Updated: Public Comment Sought on Antitrust Law Changes
The United States has published an update to its merger and acquisition guidelines, seeking public...
Sichuan Gowell Pharmaceutical Wins Reversal in Forxiga Patent Infringement Case
Sichuan Gowell Pharmaceutical Co., Ltd. has secured a favorable final judgment in its appeal against...
Biocytogen Pharmaceuticals Awarded CNIPA Patent for RenMab Human Antibody Mice Platform
Biocytogen Pharmaceuticals (Beijing) Co., Ltd (HKG: 2315), a China-based biopharmaceutical company, has announced receiving a...
Genprex Inc. Receives Chinese Patent Protection for Reqorsa Immunogene Therapy
Texas-based gene therapy company Genprex Inc., (NASDAQ: GNPX), has reported receiving a patent protection award...
US FDA Issues Warning Letter to Chengdu KeCheng Fine Chemicals Over Communication Failures
The US FDA’s Center for Drug Evaluation (CDE) issued a warning letter to China-based Chengdu...
CNIPA Launches Pilot for Priority Patent Review for Macau Applicants in Mainland China
The China National Intellectual Property Administration (CNIPA) has announced the commencement of a pilot program...